Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas

Oncogene

Volumn 28, Issue 6, 2009, Pages 854-865

  Lallemand, D ^a,b   Manent, J ^a,b   Couvelard, A ^c   Watilliaux, A ^a,b   Siena, M ^a,b   Chareyre, F ^a,b   Lampin, A ^a,b   Niwa Kawakita, M ^a,b   Kalamarides, M ^a,b,c   Giovannini, M ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c BEAUJON HOSPITAL   (France)

^d HOUSE EAR INSTITUTE   (United States)

Author keywords

Growth factor receptors; Neurofibromatosis type 2; Proliferation; Schwann cells; Schwannoma; Trafficking

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; MERLIN; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CONTACT; CELL MEMBRANE; CELL PROLIFERATION; CONTACT INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MOUSE; MUTANT; NEURILEMOMA; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SCHWANN CELL;

ANIMALS; CELL MEMBRANE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MODELS, BIOLOGICAL; NEURILEMMOMA; NEUROFIBROMIN 2; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SCHWANN CELLS; SIGNAL TRANSDUCTION;

MUS;

EID: 60149106862     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.427     Document Type: Article

References (42)

1. Bache KG, Slagsvold T, Stenmark H. (2004). Defective downregulation of receptor tyrosine kinases in cancer. EMBO J 23: 2707-2712.
2. Bretscher A, Edwards K, Fehon RG. (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599.
3. Bringold F, Serrano M. (2000). Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35: 317-329.
4. Buzard GS, Enomoto T, Anderson LM, Perantoni AO, Devor DE, Rice JM. (1999). Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea. J Cancer Res Clin Oncol 125: 653-659.
5. Cheng HL, Steinway M, Delaney CL, Franke TF, Feldman EL. (2000). IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol Cell Endocrinol 170: 211-215.
6. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI. (2007). Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177: 893-903.
7. Deretic D, Traverso V, Parkins N, Jackson F, Rodriguez de Turco EB, Ransom N. (2004). Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors. Mol Biol Cell 15: 359-370.
8. Fernandez-Valle C, Tang Y, Ricard J, Rodenas-Ruano A, Taylor A, Hackler E et al. (2002). Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31: 354-362.
9. Fraenzer JT, Pan H, Minimo Jr L, Smith GM, Knauer D, Hung G. (2003). Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int J Oncol 23: 1493-1500.
10. Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, van der Valk M, Woodruff JM, Goutebroze L et al. (1999). Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 13: 978-986.
11. Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L et al. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14: 1617-1630.
12. Hansen MR, Linthicum Jr FH. (2004). Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation. Otol Neurotol 25: 155-159.
13. Hardy M, Reddy UR, Pleasure D. (1992). Platelet-derived growth factor and regulation of Schwann cell proliferation in vivo. J Neurosci Res 31: 254-262.
14. Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M et al (2004). A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J 10: 20-26.
15. Hirschberg K, Miller CM, Ellenberg J, Presley JF, Siggia ED, Phair RD et al (1998). Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol 143: 1485-1503.
16. Hyun TS, Ross TS. (2004). HIP1: trafficking roles and regulation of tumorigenesis. Trends Mol Med 10: 194-199.
17. Itahana K, Campisi J, Dimri GP. (2004). Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5: 1-10.
18. Jones KA, Jiang X, Yamamoto Y, Yeung RS. (2004). Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport. Exp Cell Res 295: 512-524.
19. Jozwiak J. (2006). Hamartin and tuberin: working together for tumour suppression. Int J Cancer 118: 1-5.
20. Kissil JL, Wilker EW, Johnson KC, Eckman MS, Yaffe MB, Jacks T. (2003). Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol Cell 12: 841-849.
21. Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI. (2003). NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17: 1090-1100.
22. Lim JY, Kim H, Kim YH, Kim SW, Huh PW, Lee KH et al. (2003). Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway. Biochem Biophys Res Commun 302: 238-245.
23. Lobsiger CS, Schweitzer B, Taylor V, Suter U. (2000). Platelet-derived growth factor-BB supports the survival of cultured rat Schwann cell precursors in synergy with neurotrophin-3. Glia 30: 290-300.
24. Maitra S, Kulikauskas RM, Gavilan H, Fehon RG. (2006). The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling. Curr Biol 16: 702-709.
25. Manent J, Oguievetskaia K, Bayer J, Ratner N, Giovannini M. (2003). Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves. J Neurosci Methods 123: 167-173.
26. Mary S, Charrasse S, Meriane M, Comunale F, Travo P, Blangy A et al. (2002). Biogenesis of N-cadherin-dependent cell-cell contacts in living fibroblasts is a microtubule-dependent kinesin-driven mechanism. Mol Biol Cell 13: 285-301.
27. McClatchey AI, Giovannini M. (2005). Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin. Genes Dev 19: 2265-2277.
28. Miyake K, McNeil PL, Suzuki K, Tsunoda R, Sugai N. (2001). An actin barrier to resealing. J Cell Sci 114: 3487-3494.
29. Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P. (2007). Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67: 520-527.
30. Muallem S, Kwiatkowska K, Xu X, Yin HL. (1995). Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol 128: 589-598.
31. Nikitin A, Ballering LA, Lyons J, Rajewsky MF. (1991). Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci USA 88: 9939-9943.
32. Perrais M, Chen X, Perez-Moreno M, Gumbiner BM. (2007). E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 18: 2013-2025.
33. Polo S, Pece S, Di Fiore PP. (2004). Endocytosis and cancer. Curr Opin Cell Biol 16: 156-161.
34. Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M. (2003). Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 14: 2181-2191.
35. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23: 1739-1748.
36. Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC et al. (2002). Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J Clin Invest 110: 351-360.
37. Sherman L, Sleeman JP, Hennigan RF, Herrlich P, Ratner N. (1999). Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro. Oncogene 18: 6692-6699.
38. Siskova Z, Baron W, de Vries H, Hoekstra D. (2006). Fibronectin impedes 'myelin' sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Mol Cell Neurosci 33: 150-159.
39. Stanasila L, Abuin L, Diviani D, Cotecchia S. (2006). Ezrin directly interacts with the alpha1b-adrenergic receptor and plays a role in receptor recycling. J Biol Chem 281: 4354-4363.
40. Stonecypher MS, Chaudhury AR, Byer SJ, Carroll SL. (2006). Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J Neuropathol Exp Neurol 65: 162-175.
41. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G. (1999). A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 19: 2059-2068.
42. Tamma G, Klussmann E, Oehlke J, Krause E, Rosenthal W, Svelto M et al. (2005). Actin remodeling requires ERM function to facilitate AQP2 apical targeting. J Cell Sci 118: 3623-3630.